Articles with public access mandates - Yaron RotmanLearn more
Not available anywhere: 3
Nutrition literacy is not sufficient to induce needed dietary changes in nonalcoholic fatty liver disease
AM Carroll, Y Rotman
Official journal of the American College of Gastroenterology| ACG 118 (8 …, 2023
Mandates: US National Institutes of Health
Genetics of MASLD: The State of Art Update.
S Sookoian, Y Rotman, L Valenti
Clinical Gastroenterology and Hepatology, 2024
Mandates: European Commission
Authors’ Reply: Healthy Controls in Non-Alcoholic Fatty Liver Disease Management: a Biomedical Research Perspective
V Takyar, Y Rotman
Hepatology (Baltimore, Md.) 66 (3), 1007, 2017
Mandates: US National Institutes of Health
Available somewhere: 54
Emerging trends in hepatocellular carcinoma incidence and mortality
B Njei, Y Rotman, I Ditah, JK Lim
Hepatology 61 (1), 191-199, 2015
Mandates: US National Institutes of Health
The association of genetic variability in patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease
Y Rotman, C Koh, JM Zmuda, DE Kleiner, TJ Liang
Hepatology 52 (3), 894-903, 2010
Mandates: US National Institutes of Health
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Y Rotman, AJ Sanyal
Gut 66 (1), 180-190, 2017
Mandates: US National Institutes of Health
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa–dependent manner
G Ahlenstiel, RH Titerence, C Koh, B Edlich, JJ Feld, Y Rotman, ...
Gastroenterology 138 (1), 325-335. e2, 2010
Mandates: US National Institutes of Health, German Research Foundation
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
E Thomas, VD Gonzalez, Q Li, AA Modi, W Chen, M Noureddin, Y Rotman, ...
Gastroenterology 142 (4), 978-988, 2012
Mandates: US National Institutes of Health, Swedish Research Council
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
AE O’Mara, JW Johnson, JD Linderman, RJ Brychta, S McGehee, ...
The Journal of clinical investigation 130 (5), 2209-2219, 2020
Mandates: US National Institutes of Health
17‐beta hydroxysteroid dehydrogenase 13 is a hepatic retinol dehydrogenase associated with histological features of nonalcoholic fatty liver disease
Y Ma, OV Belyaeva, PM Brown, K Fujita, K Valles, S Karki, YS de Boer, ...
Hepatology 69 (4), 1504-1519, 2019
Mandates: US National Institutes of Health
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C
G Ahlenstiel, B Edlich, LJ Hogdal, Y Rotman, M Noureddin, JJ Feld, ...
Gastroenterology 141 (4), 1231-1239. e2, 2011
Mandates: US National Institutes of Health
Immunological mechanisms and therapeutic targets of fatty liver diseases
H Wang, W Mehal, LE Nagy, Y Rotman
Cellular & Molecular Immunology 18 (1), 73-91, 2021
Mandates: US National Institutes of Health
Development of a validated interferon score using NanoString technology
H Kim, AA de Jesus, SR Brooks, Y Liu, Y Huang, R VanTries, ...
Journal of Interferon & Cytokine Research 38 (4), 171-185, 2018
Mandates: US National Institutes of Health
Ribavirin improves early responses to peginterferon through improved interferon signaling
JJ Feld, GA Lutchman, T Heller, K Hara, JK Pfeiffer, RD Leff, C Meek, ...
Gastroenterology 139 (1), 154-162. e4, 2010
Mandates: US National Institutes of Health
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients
B Edlich, G Ahlenstiel, AA Zabaleta, J Stoltzfus, M Noureddin, E Serti, ...
Hepatology 55 (1), 39-48, 2012
Mandates: US National Institutes of Health
Long‐term therapy of chronic delta hepatitis with peginterferon alfa
T Heller, Y Rotman, C Koh, S Clark, V Haynes‐Williams, R Chang, ...
Alimentary pharmacology & therapeutics 40 (1), 93-104, 2014
Mandates: US National Institutes of Health
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
JJ Feld, AA Modi, R El–Diwany, Y Rotman, E Thomas, G Ahlenstiel, ...
Gastroenterology 140 (3), 830-839. e3, 2011
Mandates: US National Institutes of Health
Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
MC Podszun, AS Alawad, S Lingala, N Morris, WCA Huang, S Yang, ...
Redox biology 37, 101710, 2020
Mandates: US National Institutes of Health
Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD
S Wabitsch, JD McCallen, O Kamenyeva, B Ruf, JC McVey, J Kabat, ...
Journal of hepatology 77 (3), 748-760, 2022
Mandates: US National Institutes of Health, German Research Foundation, Doris Duke …
Kidney biomarkers associated with blood lead, mercury, and cadmium in premenopausal women: a prospective cohort study
AZ Pollack, SL Mumford, P Mendola, NJ Perkins, Y Rotman, ...
Journal of Toxicology and Environmental Health, Part A 78 (2), 119-131, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program